Effect of a novel tetrapeptide derivative in a model of isoproterenol induced myocardial necrosis

Molecular and Cellular Biochemistry

Volumn 187, Issue 1-2, 1998, Pages 173-182

  Ramesh, Chintala Venkataramana ^a   Malarvannan, Pannirselvam ^b   Jayakumar, Rajadas ^a   Jayasundar, Shanmugasundaram ^b   Puvanakrishnan, Rengarajulu ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^b MADRAS VETERINARY COLLEGE   (India)

Author keywords

Cardioprotective effect; Isoproterenol HCl; Myocardial necrosis; Tetrapeptide

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARDIOVASCULAR AGENT; ISOPRENALINE; TETRAPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEART MUSCLE NECROSIS; HEART PROTECTION; NONHUMAN; RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; ASPIRIN; BODY WEIGHT; CREATINE KINASE; DISEASE MODELS, ANIMAL; FEMALE; HEMODYNAMIC PROCESSES; HEMORRHAGE; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; LACTOFERRIN; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NECROSIS; OLIGOPEPTIDES; ORGAN SIZE; PEPTIDE FRAGMENTS; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0031714305     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006835526608     Document Type: Article

References (33)

1. Rona G, Chappel CI, Balazs T, Gaudry R: An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 67:443-455, 1959
2. Wexler BC: Myocardial infarction in young vs. old male rats: Pathophysiologic changes. Am Heart J 96: 70-80, 1978
3. Karmazn M, Moffat MP, Beamish RE, Dhalla NS: Comparative effects of acetyl salicylic acid (ASA) and sulfinpyrazone on isoproterenol induced heart damage. J Pharmacol Exp Ther 218: 764-770, 1981
4. Singal PK, Kapur N, Dhillon KS, Beamish RE, Dhalla NS: Role of free radicals in catecholamine induced cardiomyopathy. Can J Physiol Phannacol 60: 1390-1397, 1982
5. Cao AP, Loyzaga PG, Perer AM, Tamargo J: Effect of oxidipine and nitredipine on the size of experimental myocardial infarct in the rat. Pharmacol Toxicol 74: 321-329, 1994
6. Chappel CI, Rona G, Balazs T, Gaudry R: Severe myocardial necrosis produced by isoproterenol in the rat. Arch Intl Pharmacodyn Ther 122: 123-128, 1959
7. Davies MJ: The pathology of myocardial ischemia. J Clin Pathol 30: 45-52, 1977
8. Frishman WH, Burns B, Atac B, Alturk N, Altajar B, Lerrick K: Novel antiplatelet therapies for treatment of patients with ischemic heart disease: Inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor. Am Heart J 130: 877-892, 1995
9. Hennekens CH, O'Donnell CJ, Ridker PM: Current and future perspectives on antithrombotic therapy of acute myocardial infarction. Eur Heart J 16(Suppl D):2-9, 1995
10. Rihal CS, Flather M, Hirsh J, Yusuf S: Advances in antithrombotic drug therapy for coronary artery disease. Eur Heart J 16(Suppl D): 10-21, 1995
11. Lewis HD, Davis JW, Archibald DG: Protective effect of aspirin against acute myocardial infirction and death in men with unstable angina. Results of a Veterans Administration Cooperation Study. N Engl J Med 309: 396-403, 1983
12. Morishita K, Wada M,Eurnada T, Tanaka T, Tomikawa M, Iwamoto: Effect of ticlopidine and other antithrombotics on the venous thrombosis induced by endothelial damage of jugular vein in rats. Thromb Res 63: 373-384, 1991
13. Handin RI: Anticoagulant, fibrinolytic and antiplatelet therapy. In: K.J. Isselbacher, E. Braunwald, J.D. Wilson, J.B. Martin, A.S. Fauci, D.L. Kasper (eds). Harrison's Principle of Internal Medicine. McGraw Hill Inc, New York, 1994, pp 1810-1813
14. Mazoyer E, Toledano SL, Rendu F, Hermant L, Lu H, Fiat A, Jolles P, Caen J: KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.Eur J Biochem 194: 43-49, 1990
15. Drouet L, Sollier CB, Cisse M, Pignaud G, Mazoyer E, Fiat AM, Jolles P, Caen J: The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RODS. Nouv Rev Fr Haematol 32: 59-62, 1990
16. Wu G, Ruan C, Drouet L, Caen J: Inhibition effects of KRDS, a peptide derived from lactotransferrin, on platelet function and arterial thrombus formation in dogs. Haemostasis 22: 1-6, 1992
17. Ramesh CV, Jayakumar R, Kamini NR, Puvanakrishnan R: A process for the preparation of a novel peptide derivative exhibiting in vitro inhibition of platelet aggregation and antimicrobial activity. Indian Patent Application No. 1261/DEL/97.
18. Wexler BC, Kittinger GW: Myocardial necrosis in rats. Serum enzymes, adrenal steroid and histopathological alterations. Circ Res 13: 159-171, 1963
19. Besbasi FS, Hamlin RS: Influence of phenytoin on isoproterenol induced myocardial fibrosis in rats. Am J Vet Res 51: 36-39, 1990
20. King J: A routine method for the estimation of lactate dehydrogenase activity. J Med Lab Tech 16:265-272, 1959
21. Judd JT, Wexler BC: Prolyl hydrolase and collagen metabolism aller experimental myocardial infarction. Am J Physiol 228: 212-216, 1975
22. Bednar M, Smith B, Pinto A, Mullane KM: Nafazatrom induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Circ Res 57: 131-141, 1985
23. Kela AK, Reddy PL, Thombre DP: ECG findings in normal rats and after administration of isoproterenol. Ind J Physiol Pharmacol 24: 84-90, 1980
24. Ravichandran LV, Puvanakrishnan R, Joseph KT: Influence of isoproterenol induced myocardial infarction on certain glycohydrolases and cathepsins in rats. Biochem Med Metab Biol 45: 6-15, 1991
25. Mair J, Wagner I, Jakob G, Lechleitner P, Drenstl F, Puschendorf B, Michel G: Different time courses of cardial contractile proteins after acute myocardial infarction. Clin Chim Acta 231: 47-60, 1994
26. Noronha-Dutra AA, Steen EM, Woolf N: The early changes induced by isoproterenol in the endocardium and adjacent myocardium. Am J Pathol 114: 231-239, 1984
27. Zama N, Towns RLR: Effect of isoproterenol (ISO) on rat heart, liver, kidney, and muscle tissue levels of zinc, copper, and magnesium. Biol Trace Element Res 10: 189-199, 1986
28. Parratt JR, Szekeres L: Delayed protection of the heart against ischaemia. Trends Pharmacol Sci 16: 351-355, 1995
29. White FP, White SR: Isoproterenol induced myocardial necrosis is associated with stress protein synthesis in rat heart and thoracic aorta. Cardiovasc Res 20: 512-515, 1986
30. Haft JI, Kranz PD, Albert FJ, Fani K: Intravascular platelet aggregation in the heart induced by norepinephrine. Circ XLVI: 698-708, 1972
31. Wang D, Pabst KM, Adia Y, Pabst MJ: Lipopolysaccharide inactivating activity of neutrophils is due to lactoferrin. J Leukoc Biol 57: 865-874, 1995
32. Levy Toledano S, Grelac F, Caen JP, Maclouf J: KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by cycloxygenase independent mechanism. Thromb Haemost 73: 857-861, 1995
33. Leveugle B, Mazurier J, Legrand D, Mazurier C, Montreuil J, Spik G: Lactotransferrin binding to its platelet receptor inhibits platelet aggregation.Eur J Biochem 213: 1205-1211, 1993